Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Sandoz Private Limited seeks a Solution Owner – Veeva Clinical to drive end-to-end ownership of Veeva Clinical applications within the STEP program. You will provide technical direction, design governance, and lead cross-functional teams to align with the STEP roadmap and industry best practices.
The role requires 3+ years in project delivery or IT services, with expertise in Veeva Vault/Architect roles and experience in regulated environments.
The Solution Owner – Veeva Clinical is responsible for the overall application ownership, providing technical direction and domain methodology leadership in the deployment and optimisation of Veeva Clinical applications in the context of STEP. The incumbent oversees technical design, manages key vendor and internal technology relationships, and ensures that Veeva Clinical is deployed in accordance to the STEP roadmap closely aligned with the organisation’s strategic objectives and industry best practices.
Join us in building the future of Sandoz. Through STEP (Sandoz Transformation Enterprise Program), we are creating a unified, integrated digital core and simplifying our end-to-end ways of working. From SAP S/4HANA to Veeva, Workday, LabVantage, and beyond, you’ll help design and deliver future-ready systems that drive global impact — enabling us to deliver affordable medicines to more patients worldwide.
The Solution Owner – Veeva Clinical is responsible for the overall application ownership, providing technical direction and domain methodology leadership in the deployment and optimisation of Veeva Clinical applications in the context of STEP. The incumbent oversees technical design, manages key vendor and internal technology relationships, and ensures that Veeva Clinical is deployed in accordance to the STEP roadmap closely aligned with the organisation’s strategic objectives and industry best practices.
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 and while we are proud of this achievement, we have an ambition to do more! With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably.
is pioneering access for patients. As the global leader in 'off-patent' high quality medicines, we are able to make medicine more affordable and accessible. Our broad global portfolio comprises of approximately 1,300 quality biosimilar and generic medicines, enabling us to provide more than 900 million patient treatments across 100+ countries per year, and while we are proud of this achievement, we have an ambition to do more! Powered by our talented and ambitious colleagues, who, in return for dedication and skills, experience a flexible, collaborative & inclusive culture where diversity of thought is welcomed and where personal growth is nurtured!